Heterocyclic compounds of benzimidazole and oxadiazole are considered as important class of compounds in medicinal chemistry because of their interesting diversified biological activities. A series of new benzimidazole bearing oxadiazole derivatives have been conveniently synthesized by intermolecular oxidative cyclization of benzimidazole benzoyl hydrazide promoted by iodobenzene diacetate as an oxidant. The structures of the synthesized compounds were characterized by spectroscopic methods namely 1 H Nuclear Magnetic Resonance (NMR), Infrared (IR), Mass Spectrometry (MS) and melting point.
Introduction
Benzimidazole and oxadiazole have received attention in recent years due to widespread applications notably in the field of medicinal chemistry due to their privileged biological activity. Recently, benzimidazole derivatives have been reported as antidiabetic [1] , antimicrobial [2] [3] , antiviral [4] [5] [6] antispasmodic [7] and antiasthmatic [8] agents. Similarly, oxadiazole derivatives are also recognized for their pharmacological importance and are reported to possess wide spectrum of activities such as antibacterial [9] [10] [11] , antifungal [12] anti-inflammatory [13] [14] analgesic [15] , anticonvulsant [16] [17] , hypoglycemic [18] and anticancer [19] properties. The synthesis of both compounds has emerged as an essential need for development of new pharmaceutical entities. 
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Pale yellow powder, yield: 0.082 g (82%); m. 5,6-dimethyl-1H-benzo[d]imidazol-2-yl)phenyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole (20 5,6-dimethyl-1H-benzo[d]imidazol-2-yl)phenyl)-5-(4-methoxyphenyl)-1,3,4-oxadiazole (21 -tolyl)-1,3 The synthesis of the target compounds began with the synthesis of sodium metasulfite adduct according to the literature protocol [5] . The resulting sulfite adduct was refluxed with 4,5-dimethyl-O-phenylenediamine in DMF for 6 h to give the arylester substituted benzimidazole. The benzohydrazide of benzimidazole was formed by refluxing arylester of benzimidazole with methanolic hydrazine hydrate (Scheme 1). The synthesis of benzimidazole benzohydrazide Schiff bases (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) was accomplished by reacting different aldehydes with benzimidazole benzohydrazide in n-butanol in the presence of a catalytic amount of acetic acid as shown in Scheme-1. A series of new 2, 5-disubstituted-1,3,4-oxadiazoles (Table 1) The IR spectra of the synthesized compounds exhibited characteristic absorption bands at 1600 -1700 cm -1 and 3100 -3300 cm -1 due to carbonyl or C=N; and NH group, respectively. The 1 H NMR spectra of compounds 1-14 showed two singlets due at N=CH and NH, respectively. The structure of all compounds was confirmed by their spectral data (IR, 
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